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Abstract 
Future improvements of non-viral vectors for siRNA delivery require better understanding of 
intracellular processing and vector interactions with target cells. Here, we have compared the 
siRNA delivery properties of a lipid derivative of bPEI 1.8kDa (DOPE-PEI) with branched 
polyethyleneimine (bPEI) with average molecular weights of 1.8kDa (bPEI 1.8kDa) and 25 kDa 
(bPEI 25kDa). We find mechanistic differences between the DOPE-PEI conjugate and bPEI 
regarding siRNA condensation and intracellular processing. bPEI 1.8kDa and bPEI 25kDa have 
similar properties with respect to condensation capability, but are very different regarding siRNA 
decondensation, cellular internalization and induction of reporter gene knockdown. Lipid 
conjugation of bPEI 1.8kDa improves the siRNA delivery properties, but with markedly different 
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formulation requirements and mechanisms of action compared to conventional PEIs. Interestingly, 
strong knockdown using bPEI 25kDa is dependent on the presence of a free vector fraction which 
does not increase siRNA uptake. Finally, we have investigated the effect on lysosomal pH induced 
by these vectors to elucidate the differences in the proton sponge effect between lipid conjugated 
PEI and conventional PEI: Neither DOPE-PEI nor bPEI 25kDa affected lysosomal pH as a function 
of time, underlining that the possible proton sponge effect is not associated with changes in 
lysosomal pH. 
Keywords: Non-viral gene delivery, siRNA, Polyethyleneimine, Proton sponge effect, Polycation 
 
1. Introduction 
RNA interference (RNAi) based drugs are currently under intense investigation for treating viral 
infections, cancer and neurological disorders [1].  RNAi is a naturally occurring post-transcriptional 
gene-silencing mechanism for regulation of gene expression through degradation or translation-
arrest of the target mRNA [2]. The most extensively described form of RNAi acts through small 
interfering RNAs (siRNAs), which have very high (≈100%) sequence similarity with the target 
mRNA. The siRNAs can be transfected into cells in their short active form or generated 
intracellularly from longer double stranded RNAs (dsRNAs) [3,4].  
The safe and efficient delivery of siRNA specifically to target cells is essential to RNAi-based 
therapy, but remains a major challenge [5]. Many attempts have relied on modified viruses, which - 
while very efficient - suffer from safety, immunogenicity and scalability issues [6]. As a 
consequence, non-viral vectors, which are characterized by low host immunogenicity and easy 
manufacturability, have attracted considerable attention and successful development of a safe and 
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efficient non-viral delivery system would be one of the most important achievements in medicine 
today [7,8].  
Cationic polymers are attractive for delivery of siRNA (and DNA) since they are particularly easy 
to formulate with poly-anionic nucleic acids. The electrostatic interactions between the anionic 
phosphates in siRNA and cationic moieties in the polymers can assemble the siRNA into 
nanoparticles - polyplexes - suitable for cellular uptake. Vectors based on polyethylenimine (PEI) 
were among the first to emerge and are still considered the gold standard in polymer based DNA 
delivery [9–12] and have also turned out to be efficient siRNA delivery agents in vitro [13–15].  
In spite of the huge activity in the field and the broad use of cationic polymers as siRNA delivery 
agents, several aspects about the mode of action remain unclear. Polyplexes are generally believed 
to enter the cell via endocytosis, thus a primary research focus has been to ensure endosomal escape 
to avoid degradation in the lysosomes [16,17] and achieve release of the cargo into the cytosol. One 
of the key advantages of cationic polymers is their alleged ability to facilitate the so-called proton 
sponge effect [9], which is believed to be associated with endosomal escape of the polyplexes or 
their components. In PEI, the many protonated amines facilitate polyplex formation, while the 
unprotonated amines are able to absorb protons when the complex enters acidic compartments 
(endosomes and lysosomes). The proton sponge effect is believed to result in excessive V-ATPase 
mediated H+ influx, which leads to increased influx of Cl- and water, and in turn this may lead to 
osmotic swelling, destabilization and/or rupture of the lysosomal membrane and release of the 
siRNA into the cytosol [18]. However, the proton sponge effect is debated and incontrovertible 
experimental evidence remains elusive. An alternative hypothesis is that polyplexes are internalized 
via the caveolar pathway that bypasses the endolysosomal pathway altogether [19], but the 
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existence of a physiologically relevant caveolar pathway with a role in constitutive endocytic 
trafficking is equally debated [20–22].  
One limitation of PEI as a transfection agent has been that both toxicity and delivery efficiency 
correlates with average molecular weight (MW) [23], and an average MW of 25kDa is generally 
considered the upper limit before the toxicity becomes problematic [11]. Several strategies have 
been devised to preserve the low toxicity of low-MW PEI but improve the delivery capability. One 
promising approach has been to incorporate hydrophobic moieties onto the polymer amines of e.g. 
PEI 2kDa [24] to increase the transfection efficiency, potentially by increasing the interaction of the 
polymer with the cell membrane. Such a beneficial effect of lipid substitution has been established 
in the context of plasmid DNA delivery for several cationic carriers [25,26] and more recently for 
delivery of siRNA [24,27–29].  
An important aspect of polycation based gene delivery is the polymer/siRNA ratio necessary to 
obtain high transfection efficiency. This issue has been addressed thoroughly for PEI mediated 
DNA transfection [30–32], where it was found that a free (non-condensed) fraction of PEI is very 
important for achieving high transfection levels. However, as size, electrostatic charge and 
intracellular compartment of action differ for siRNA compared to DNA, it is not clear how a free 
fraction of PEI influences gene silencing. For in vivo use, a potential requirement for a free fraction 
for achieving high gene silencing efficiency is a major obstacle for the use of PEI and other 
polycations for non-viral gene delivery. Such systems are challenged by the fact that highly cationic 
entities will interact strongly with anionic blood constituents, the immune system and cells in 
general, and will therefore not allow for targeting of diseased tissue. In order to rationally develop 
efficacious siRNA carriers, it is essential that the interplay between the above-mentioned properties 
are understood.  
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In the present study we have compared lipid derivatized bPEI with conventional bPEI 1.8kDa and 
bPEI 25kDa. Our PEI derivative is a conjugate of dioleoylphosphatidylethanolamine (DOPE) and 
bPEI 1.8kDa, which we refer to as DOPE-PEI throughout this text. bPEI 25 kDa serves as a point of 
reference as delivery efficiency of conventional PEI correlates with average MW and 25 kDa is 
widely accepted to be the highest useful average MW before cytotoxicity becomes problematic 
[11]. We establish to what extent the lipid conjugation alters the condensation properties of siRNA, 
cellular delivery and silencing of a reporter gene as well as to what extent the lipid conjugation 
reduces the toxicity of bPEI. We further investigate and compare how PEI and lipid conjugated PEI 
affect the pH in the lysosomes, as an increase in lysosomal pH has been associated with the proton 
sponge effect. Lastly, we systematically investigate the impact of lipid conjugation to bPEI in 
relation to the use of excess transfection agent beyond the requirement for full condensation of the 
siRNA (termed the “free fraction”) and the silencing efficiency in comparison to bPEI itself. 
Although lipid conjugation affects the behavior of PEI and possibly the structure of the particles 
formed with siRNA, we have chosen to refer to all the used vectors as polymers forming 
polyplexes. 
2. Materials and Methods 
2.1 Materials and cell lines 
Branched PEI with a weight-averaged molar mass of 25,000 g/mol (bPEI 25kDa) and 1,800 g/mol 
(bPEI 1.8kDa) were purchased from Sigma-Aldrich (US) and used without further purification. 
Before use they were dissolved in MQ water to a concentration of 15.4 mM with respect to nitrogen 
and further diluted in Hepes buffed glucose (HBG: 10 mM Hepes, 5% w/v glucose, pH 7.4) as 
needed. DOPE-PEI was synthesized from PEI 1.8kDa and glutaryl-modified DOPE (NGPE) as 
described in [26], and kindly supplied by Professor Vladimir Torchilin’s laboratory as a lyophilized 
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powder. Briefly, NGPE in chloroform was activated with N-(3-dimethylaminopropyl)-N´-
ethylcarbodiimide HCl (EDCI) and N-hydroxysuccinimide (NHS) in the presence of triethylamine 
at room temperature (RT) for 4 h. PEI 1.8 kDa was dissolved in chloroform and the activated acid 
solution was added drop-wise into the PEI solution while stirring and the mixture was stirred at RT 
overnight. The chloroform was evaporated in a rotary evaporator and freeze-dried to remove traces 
of chloroform. The residue was suspended in 2 ml of deionized water (dH2O) and purified by 
dialysis (MWCO 2 kDa) against dH2O and freeze-dried. The product was dissolved in chloroform 
and characterized by 1H NMR using a Varian 500 MHz spectroscope. Using the standard pyrene 
method, the CMC of DOPE-PEI was determined to be 0.034 mg/ml (0.013 mM) [26]. Before use 
DOPE-PEI was dissolved in MQ water to a concentration 15.4 mM with respect to nitrogen (1 
mg/mL) and further diluted in HBG as needed. All siRNA duplexes were purchased from Eurofins 
MWG Operon (Germany): siRNA targeting green fluorescent protein (GFP-siRNA): 5′-
GGCUACGUCCAGGAGCGCACC(dTdT)-3′ (sense) and siRNA targeting Luciferase (5′-
CUUACGCUGAGUACUUCGA(dTdT)-3′ (sense). PicoGreen and Lipofectamine® RNAimax 
were purchased from Invitrogen (US) and Na-Heparin from porcine intestinal mucosa was 
purchased from Sigma-Aldrich (US). The CellTiter 96® AQueous Non-Radioactive Cell 
Proliferation Assay (MTS) was purchased from Promega (US).  
The cell line HT1080 (human fibrosarcoma, ATCC no. CCL-121) was transfected to stably express 
luciferase and is referred to as HT1080pLUC. The cells were cultured at 37°C, 5% CO2 in RPMI 
1640 (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, heat-inactivated, Fisher 
Scientific), penicillin at 100 units/mL (pen), streptomycin at 100 mg/mL (strep), and Genticin 
(G418) at 0.8 mg/mL (all from Sigma-Aldrich). For knockdown experiments the selection 
antibiotic, G418, was omitted from the culture medium. 
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2.2 Preparation of polyplexes 
The N/P ratio of the present polyplexes is defined as the molar ratio of the total number of nitrogen 
atoms in the PEI segment of the polymer or lipid-conjugated polymer to the number of siRNA 
phosphates. Polyplexes with varying N/P ratios were formulated by adding a volume (≈35 µL) from 
a siRNA solution in water to an equal volume of a solution of cationic polymer diluted in HBG. The 
final siRNA concentration was kept constant while the bPEI concentration was varied with the 
different N/P ratios. Each resulting formulation mixture was first mixed by pipetting up and down 
10 times, then vortexed gently for 15 s and then incubated for 45 min at RT before further use. The 
final concentration of siRNA in all formulation mixtures was 0.039 µg/uL. 
2.3 Size and zeta potential of polyplexes  
The hydrodynamic diameter (particle size), polydispersity and zeta potential of the polyplexes were 
determined using dynamic light scattering (DLS) on a ZetaPals (Brookhaven Instrument 
Corporation, Holtsville, NY, USA) at 25°C with an angle of 90°. Data was recorded using 
Brookhaven Instrument Corporation’s Particle Solutions software. Before zeta potential 
measurements the electrode was conditioned in a 1 M KCl solution. Polyplexes were prepared as 
described above and diluted up to a volume of 1.75 mL in HBG and measured immediately after 
preparation. The particle size was determined by five runs of 30 s each on three separate 
preparations. Zeta potential determination of each sample was carried out by 10 runs with a target 
residual of 3.5 x 10-2, three separate preparations per N/P ratio. 
2.4 Polyplex formation and dissociation analysis by PicoGreen exclusion assay 
The complex formation between siRNA and the cationic polymers was studied in an exclusion 
assay using the fluorescent intercalating dye PicoGreen. PicoGreen shows maximum fluorescence 
at 535 nm when it intercalates between the bases in double stranded RNA (and DNA) while 
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showing virtually none in the absence of intercalation, and is thus a highly sensitive detector of 
accessible siRNA, in this case meaning uncomplexed siRNA. Polyplexes were prepared at different 
N/P ratios at RT as described above and transferred to a dark microtiter plate and PicoGreen 
solution was added. The fluorescence of the polyplex dispersions (λex = 485 nm, λem = 535 nm) was 
measured 10 min after addition of PicoGreen on a Victor 3 plate reader (Perkin-Elmer, US) using 
Wallac 1420 Workstation vs 3.0 software. 
To study the dissociation of the polyplexes when exposed to a competing polyanion, increasing 
amount of heparin was added to the polyplex dispersions after 45 min incubation. When the 
negatively charged heparin is added to the dispersions of the polyplexes, it competes with the 
siRNA for binding to the cationic bPEI, potentially leading to the displacement of siRNA from the 
polyplex. The resulting mixtures were incubated for 30 min at RT and measured on the Victor 3 
plate reader. The relative fluorescence values and thus the percentage of accessible (= uncondensed) 
siRNA were determined and reported as percent fluorescence of free siRNA in the absence of 
vector. All results are corrected for fluorescence quenching by heparin and each experimental 
condition was done in triplicates. 
2.5 Polyplex formation visualization by gel electrophoresis 
The polyplex formation between siRNA and the polycations was further evaluated using agarose 
gel electrophoresis; exploiting the fact that naked siRNA readily migrates in an agarose gel while 
polyplexes are retained in the wells. Each preparation of polyplex with a desired N/P ratio was 
loaded onto a 2% (w/v) agarose gel containing ethidium bromide (Sigma-Aldrich) in Tris-Acetate 
EDTA buffer. The amount of siRNA loaded into each well was 69 pmol in a total volume of 12 µL 
including loading buffer (1 mM cresol red in 0.6 M sucrose). The electrophoresis was performed at 
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50 V for 35 min and siRNA bands were visualized using a BioSpectrum® Imaging System with the 
VisionWorksLS software package (excitation at 480 nm, emission filter at 570-640 nm.) 
2.6 Knockdown of luciferase 
HT1080 pLuc cells, which stably expressed luciferase, were seeded in RPMI 1640 medium with 
10% FBS, 5% pen/strep (complete medium) in 24-well plates 24 h prior to transfection (50,000 
cells per well). The cells were washed with PBS, polyplexes formulated as described above were 
further diluted in RPMI 1640 medium with 5% pen/strep (serum free medium) and added to the 
cells resulting in a final concentration of 120 nM siRNA per well. The cells were incubated with 
polyplexes for 6 h, transfection medium was removed, and the cells were washed with PBS and 
incubated for an additional 22 h in complete medium. The cells were then washed once with PBS 
and lysed using 125 µL Reporter Lysis Buffer (Promega, US). Luciferase activity was measured 
using a luciferase assay [33] with D-luciferin (Caliper Life Sciences, US). Each sample was 
measured for 10 s on a luminometer (Lumat LB9507 with Lumat firmware, Berthold, Germany). 
The total lysate protein concentration was determined using the BCA kit (Pierce, US) and the gene 
expression was normalized to the total protein concentration in the cell lysate and described as 
luciferase activity (relative light units) per µg protein. All knockdown assays comprised, as a 
positive control, Lipofectamine® RNAimax using 30 pmol of siRNA. In addition, all assays 
comprised a non-sense control using siRNA directed against GFP as well as anti-luciferase siRNA 
administrated unassociated to vector. The non-sense control was prepared using N/P16 for DOPE-
PEI and N/P3 for bPEI 25kDa and PEI 1.8kDa. Each experimental condition was done in triplicates. 
For experiments to examine the importance of the free fraction, the extra vector material was 
diluted in serum free medium and added to cell cultures which had already been incubated for 2 h 
with polyplexes formulated for full condensation of the siRNA. Specifically, HT1080pLuc cells 
10	
	
were incubated with polyplexes formed at the N/P ratio of full condensation for 2 h (N/P2 for bPEI 
25kDa and N/5 for DOPE-PEI). Then, the free fraction was added to the incubations, resulting in a 
total N/P ratio of 3 for bPEI 25kDa and 16 for DOPE-PEI. The cultures were then incubated with 
the mix of fully condensed polyplexes and separately added free fraction for 1, 2 or 4 h resulting in 
a total incubation time of 3, 4 or 6 h. After end of incubation with the mix of polyplexes and 
separately added free fraction, the cells were washed in PBS, fresh complete medium was added 
and the cells were incubated to a total of 28 h until lysis and analysis of gene knockdown. Control 
cells were incubated in parallel with fully condensed polyplexes or optimally formulated 
polyplexes. Each experimental condition was done in triplicates. 
2.7 Radiolabeling of siRNA 
Luc siRNA (MWG Eurofins Operon, Germany) was labeled with radioactive 33P using the kit for 
phosphorylation of DNA with T4 Polynucleotide Kinase (Fisher Scientific, US). The T4 
Polynucleotide Kinase was used to catalyze the transfer of 33P from [γ-33P]-ATP (Perkin Elmer, US) 
to the free hydroxyl end (5’) of luciferase siRNA. The reaction was stopped by addition of EDTA 
and the product was purified using the QIAquick nucleotide removal kit (Qiagen, Germany). Care 
was taken not to damage any secondary structure of the siRNA, accordingly the reaction mixture 
was never heated above 40°C. 
2.8 In vitro cellular uptake 
For experiments with parallel determination of uptake and knockdown, the siRNA was spiked with 
33P labeled siRNA. Knockdown assays were performed as described above and the experiments 
were terminated by removal of the medium and the cells were washed with PBS containing 0.11 
mg/mL heparin in order to remove polyplexes bound to the plasma membranes and once with PBS. 
The cells were then lysed as described above, luciferase and BCA assays were performed and 65 µL 
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lysate per population was mixed with 5 mL scintillation liquid (UltimaGold, Perkin Elmer, US) and 
radioactivity was measured as counts per minute using a Packard Tri-carb Liquid Scintillation 
Analyzer 1900CA (Packard Biosciences, US) equipped with Packard firmware. Each experimental 
condition was done in triplicates. 
2.9 Cytotoxicity of polymers and polyplexes  
The cytotoxicity of free vector polymers and the corresponding polyplex dispersions was evaluated 
on HT1080 pLuc cells using the MTS assay (CellTiter 96® Aqueous Non-Radioactive Cell 
Proliferation assay, Promega, USA). Cells were seeded in a 96-well plate at an initial density of 
10,000 cells per well in complete medium. After 24 h, free vector polymers or polyplexes were 
added to the cells at varying concentrations in serum free medium. The cells were incubated at 
37°C, 5% CO2 for 24 h. The MTS working solution was then added to each well (20 µL). The cells 
were further incubated for 1 h at 37°C and absorbance was measured (490 nm, Victor 3 plate reader 
with Wallac 1420 Workstation vs 3.0 software). Cytotoxicity was reported as percent cell viability 
using untreated cells as 100% (triplicate measurements). 
2.10 Ratiometric pH measurements in the lysosomal compartment 
Measurements of lysosomal pH were performed with a triple-labelled fluorescent nanosensor as 
described in our published protocol and review [34,35]. Briefly, HT1080 cells were plated in Ibidi 
8-well µ-slides (27,000 cells/well in 300 µL/well) in complete medium and incubated overnight. On 
day 2, medium was changed to complete medium with 25 µg/mL nanosensor. On day 3, cells were 
carefully washed once in PBS-Heparin (0.111 µg/mL heparin in PBS) and once in PBS in order to 
remove un-internalized nanosensor. Then vector polymers were added in the following 
concentrations: 0.73 µg/mL (bPEI 1.8kDa, bPEI 25kDa) and 5.7 µg/mL (DOPE-PEI) in imaging 
medium (full growth medium without phenol red). These concentrations are 10% higher than for 
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any in vitro cell assay with polyplexes, but below a level where significant cytotoxicity is observed. 
Confocal images were recorded at 0, 2 and 6 h, where after the cells were washed once in PBS-
Heparin and once in PBS and kept in imaging medium. Additional images were then acquired 10 
and 24 h after addition of bPEI. Images were captured by a Leica TCS SP5 confocal microscope 
with a 63x water-immersion objective. The microscope is equipped with an incubator box and CO2 
supply for optimal growth conditions during imaging. Images were acquired with fixed settings for 
all samples and the corresponding calibration curve. We used Leica Application Suite for Advanced 
Fluorescence for data recording and in-house developed software for ratiometric pH calculations.  
Two-color images were obtained by sequential line scanning with the following excitation/emission 
wavelengths: 488/493-560 nm and 561/566-680 nm. At each time point, before imaging the PEI 
treated cells, a control experiment was performed in order to optimize the microscope settings. One 
well containing cells unexposed to bPEI or PEI-derivative, but with nanosensor, was treated with 
200 nM Bafilomycin A1 for 40 min and used to optimize microscope settings. This treatment 
increases the pH of the lysosomes and adjusting the imaging settings to achieve maximum signal 
for this sample, ensures optimal use of the dynamic range of the nanosensor. Ten images were 
acquired of this sample and of an untreated sample (no PEIs or Bafilomycon A1, but with 
nanosensor) where after 15 images were acquired of each of the three PEI samples (per time-point). 
A calibration curve was prepared by diluting the nanosensor in buffers (20 mM phosphate/20 mM 
citrate/20 mM malate/100 mM NaCl) from pH 2.8-7.5 with a final nanosensor concentration of 10 
mg/mL. Each solution (2.5 µL) was transferred to a diagnostic microscope slide, sealed with a 
cover glass and imaged. The calibration curve was fitted to the following equation for a triple-
labeled nanosensor: 
𝑅 = 𝑅!10!"#!!!" + 1+ 𝑅!10!"#!!!" + 1+ 𝑅! 
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where R is the ratio of emission intensities excited at 488  and 561 nm, R0 = Rmin (the ratio for the 
fully protonated form), (R0+R1+R2) = Rmax (the ratio of the fully deprotonated form), and pKa1 and 
pKa2 are the specific pKa values of the two pH-sensitive fluorophores in the nanoparticle. Image 
analysis was performed as described previously using a pixel based method [34,36]. Briefly, image 
processing was used in order to determine which pixels are actual signal from the nanosensor and 
the included pixels were then converted to pH via the calibration curve. pH histograms are 
presented as mean ± SEM. pH images were generated by coloring single pixels according to a linear 
pH color scale. Additionally, phase contrast images were acquired at 2, 6, 10 and 24 h time-points 
to confirm cell viability and illustrate non-toxic footprint of nanosensor. 
2.11 Statistical Analysis 
Statistical analysis was performed using Prism 6 (Graphpad Software, US). Each experiment was 
performed at least three times with triplicate measurements. Unless otherwise stated, data points 
represent mean of triplicate ± SD. Trend lines are 4 or 5 parameter fits. Statistical analysis used t-
test with significance levels being symbolized by * if p<0.005 and ** if p<0.001. 
 
3. Results 
3.1 Cytotoxicity of vector polymers and polyplexes 
To establish the toxicity profiles of bPEI 25kDa, bPEI 1.8kDa and DOPE-PEI, we used a cell 
viability assay (Promega’s MTS kit) to investigate the free vector polymers (Fig. 1) and the siRNA 
containing polyplexes (Fig. 2). 
Fig. 1 shows that all three polymers are associated with some cytotoxicity with bPEI 25kDa being 
the most cytotoxic. Importantly, formulation of the vectors into polyplexes greatly diminishes this 
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inherent cytotoxicity, most pronounced for bPEI 25kDa and DOPE-PEI (Fig. 2). The selected N/P 
ratios are those involved in subsequent in vitro knockdown studies as described in detail later. 
3.2 Lysosomal pH 
The proton-sponge effect remains the dominant hypothesis used to explain the ability of PEI to 
promote high transfection levels, and this effect has been hypothesized to result in increased pH 
levels in the lysosomes. We therefore measured the lysosomal pH in cells incubated with PEI 
1.8kDa, DOPE-PEI, and bPEI 25kDa using a triple-labeled ratiometric nanosensor that we have 
developed [34,36,37] to compare the lipid conjugated PEI with conventional PEIs. This nanosensor 
with the two pH-sensitive fluorophores Oregon Green and fluorescein and the pH-insensitive 
fluorophore rhodamine B is superior to earlier reported pH sensors with respect to the sensitivity 
range (pH 3.2-7.0), especially when obtaining measurements in the lysosomes [36]. 
For the lysosomal pH measurements, cells were treated for 24 hours with the nanosensor and then 
exposed to the different PEIs and imaged by confocal microscopy at different time points. Fig. 3A 
shows that the pH distributions obtained from cells treated with bPEI 25kDa or DOPE-PEI do not 
differ from those obtained from the untreated control cells. As a positive control, we treated cells 
with the Vacuolar-type H+-ATPase (V-ATPase) inhibitor Bafilomycin A1, which is known to 
inhibit the acidification of the lysosomes. This sample displayed a significant increase in pH, up to 
around pH 6.0, which is in agreement with previously published results [38,39], confirming that the 
nanosensor is capable of measuring an increase in pH. As Bafilomycin A1 is an inhibitor of the V-
ATPase it does not block the action of the pump completely, which is why we do not observe pH 
values closer to the physiologically neutral level of pH 7.4. The lysosomal pH is visually presented 
in Fig. 3B which shows images from the 6 h time-point. A lack of change in color between the 
Control and DOPE-PEI treated cells indicates no change in lysosomal pH. Finally, the pH as a 
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function of time is presented in Fig. 3C for the Control and DOPE-PEI treated samples under 
exactly the same conditions over a period of 24 h, and no change in pH is observed over time. It is 
important to keep in mind that the nanosensor resides in the lysosomes, and that the reported pH 
measurements exclusively regard lysosomal pH irrespective of when the polyplexes may reach this 
compartment. Conclusively, we do not find that lipid conjugated PEI changes the pH in the 
lysosomal compartment, which is thereby similar to our previous study evaluating the proton 
sponge effect of conventional PEI [35]. 
Phase contrast images (Supplementary Fig. 1) indicate that the combined exposure to nanosensor 
and bPEI / bPEI-derivative has a minimal impact on cell viability at the concentrations used. 
Furthermore, we have previously established that the nanosensor does not affect cell viability 
[34,35]. 
3.3 Size and zeta potential of the polyplexes 
Size and charge of polyplexes greatly influences the efficiency of cellular uptake. Therefore, the 
complex formation of bPEI 1.8kDa, bPEI 25kDa and DOPE-PEI with siRNA was characterized. In 
HBG, all three vectors are able to condense the siRNA cargo into small particles with DOPE-PEI 
consistently forming the smallest particles (Fig. 4A). The zeta potentials of the polyplexes are 
positive at N/P ≥ 3 for bPEI 1.8kDa and bPEI 25kDa, or at N/P ≥ 6 for DOPE-PEI. The higher N/P 
ratio for transition from negative to positive zeta potential for DOPE-PEI reflects the altered 
condensation properties of this vector due to the lipid conjugation. 
3.4 Condensation and decondensation properties of the polyplexes 
The balance between cargo condensation extracellularly and dissociation intracellularly is crucial 
for efficient transfection and previous reports have indicated full condensation of siRNA cargo by 
bPEI 1.8kDa at N/P2 and DOPE-PEI at N/P3 [29]. We examined the ability of all three polymers to 
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condense siRNA using the PicoGreen exclusion assay as well as gel-shift assays. The differences in 
condensation behavior of the three polymers are depicted in Fig. 5, which shows that bPEI 1.8kDa 
and bPEI 25kDa reaches full and similar condensation of the siRNA at N/P2 in agreement with 
literature [29]. In contrast, DOPE-PEI does not reach full condensation until N/P5. These results are 
supported by the gel-shift assays (Supplementary Fig. 2) as well as the zeta potential measurements 
(Fig. 4B), which all indicate altered lipid-siRNA interaction due to the lipid conjugation.  
Anionic competition for binding to the vector polymers is one way to assess the strength of the 
siRNA-vector association, and we therefore monitored the heparin-induced release of siRNA or 
decondensation of the polyplexes through the fluorescence intensity of PicoGreen (Fig. 6). 
Surprisingly, bPEI 25kDa polyplexes were the most vulnerable to competition from heparin as they 
decondense to a level of 40% PicoGreen accessibility (percentage relative to free siRNA). In 
contrast, bPEI 1.8kDa and DOPE-PEI reaches plateaus of PicoGreen accessibility of only 5% and 
10%, respectively.  
3.5 In vitro knockdown studies 
To systematically analyze and compare the performance of bPEI 25kDa, bPEI 1.8kDa and DOPE-
PEI as delivery agents of siRNA, we established the optimum balance between knockdown and 
induction of cytotoxicity in an HT1080pLUC cell line. bPEI 1.8kDa was unable to suppress 
expression of luciferase, while bPEI 25kDa showed efficient knockdown, reaching a plateau of 
maximum knockdown at N/P3. Lipid conjugation of bPEI 1.8kDa transformed the polycation into 
an efficient transfection agent reaching a plateau of maximum knockdown at N/P16 (Fig. 7). Above 
these N/P ratios the cytotoxic impact of the polyplexes gradually became apparent. We therefore 
conclude that bPEI 25kDa at N/P3 and DOPE-PEI at N/P16 strikes an optimal balance between 
knockdown and absence of cytotoxicity and regarded these formulations as optimal. For referencing 
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with Fig. 1 and 2, these N/P ratios translate to 0.67 µg/mL (bPEI 1.8kDa and 25kDa) and 5.2 
µg/mL (DOPE-PEI) in our in vitro assays, where none of the transfection systems show toxicity.  
The results of Fig. 3-7 demonstrate that the full transfection potential of each vector is realized at 
higher N/P ratios than where full siRNA condensation is observed. However, compared to similar 
experiments with DNA using bPEI 25kDa [30], it is notable that the N/P ratio necessary to achieve 
maximum knockdown is much lower with siRNA than DNA cargo (N/P3 vs N/P8, respectively). 
As efficient knockdown required use of vector material in excess of what was required for full 
siRNA condensation, we wanted to investigate the role and importance of this vector fraction 
(which we have termed the “free fraction”) and how the lipid conjugation affected the behavior of 
the free fraction compared to the conventional bPEI 25kDa (Fig. 8). This was assessed as the ability 
of the free fraction to improve the knockdown capability of polyplexes formed at the N/P ratio for 
full condensation. We therefore incubated our reporter cell line with fully condensed polyplexes for 
two hours, added free vector, incubated further, washed to remove uninternalized material, 
incubated to a total of 28 h and analyzed knockdown. 
DOPE-PEI and bPEI 25kDa differ in the degree to which delayed addition of the free fraction 
results in as large a knockdown as optimal N/P ratios. For bPEI 25kDa, delayed addition of the free 
fraction results in a knockdown, which is statistically identical to the populations that were 
incubated with polyplexes formulated with the optimal N/P ratio (Fig. 8A-C). For DOPE-PEI, 
delayed addition of the free fraction increases the knockdown but not to the level of optimally 
formulated particles (N/P16) (Fig. 8D-F), indicating that lipid conjugation also influences the 
interaction of the vectors with the cells. 
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3.6 Uptake 
To elucidate how the N/P ratio influenced the uptake and concomitant knockdown, and to see if 
polyplexes of DOPE-PEI behaved differently than polyplexes of conventional bPEIs, we performed 
in vitro knockdown assays using radioactively labeled Luciferase siRNA (Fig. 9).  
The knockdown profiles in Fig. 9 confirm the trends from Fig. 8, i.e. a large knockdown by 
RNAimax (85%), bPEI 25kDa at N/P3 (77%) and DOPE-PEI at N/P16 (86%), a small knockdown 
by bPEI 25kDa at N/P2 (34%) and complete absence of knockdown from bPEI 1.8kDa at N/P2 and 
3, DOPE-PEI at N/P5 and uncomplexed siRNA. These observations correlate well with the uptake 
data, to the extent that bPEI 25kDa at N/P3 and DOPE-PEI at N/P16 show relatively high siRNA 
uptake levels compared with very low uptake levels for bPEI 1.8kDa at N/P2 and 3 and 
uncomplexed siRNA. However, considerable complexity is added by the following observations: 1) 
bPEI 25kDa at N/P2 consistently induces a significantly higher siRNA uptake than bPEI 25kDa at 
N/P3 (p<0.001), but bPEI 25kDa at N/P2 induces only a small knockdown, 2) DOPE-PEI at N/P5 is 
taken up to a considerable extent but induces no knockdown, and 3) RNAimax is never internalized 
to more than 2% of the available siRNA but remains as efficacious as DOPE-PEI at N/P16 and 
bPEI 25kDa at N/P3.  
 
4. Discussion  
Safe and efficient delivery of siRNA to the cytoplasm of target cells is a prerequisite for knockdown 
of a target gene. To enable rational and focused design of siRNA delivery systems, detailed 
knowledge of the interaction between the vector polymers and the siRNA as well as between the 
polyplexes and the cells is necessary. PEI has been extensively characterized for DNA delivery 
[30–32,40]. For instance, it has been shown that high efficiency requires N/P ratios > 8 [30,40], 
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while full condensation of the DNA is reached at N/P3-4 [30,31,41]. This indicates that a fraction of 
the vector has a role unrelated to condensation of DNA, and this fraction has been speculated to be 
free in solution or at least only weakly associated to the nucleic acid-containing polyplex. siRNA 
delivery by PEI has been much less studied, but as size and electrostatic density of the cargo as well 
as intracellular compartment and molecular machinery of action differs for siRNA in comparison to 
DNA, it is not possible to directly extrapolate mechanistic results from DNA to the delivery of 
siRNA [42]. Therefore, the mechanistics of siRNA delivery using bPEI and the lipid conjugate of 
bPEI has been investigated in this study. 
At similar polycation concentrations, fully condensed polyplexes based on DOPE-PEI display 
lower cytotoxicity than fully condensed polyplexes with bPEI 1.8kDa and bPEI 25kDa (Fig. 2, 
filled symbols). Further, at our assay concentrations, lipid conjugation of bPEI 1.8kDa has not 
increased the inherent cytotoxicity of bPEI 1.8kDa (Fig. 1) in spite of DOPE having high membrane 
affinity and fusogenic capability [43,44]. However, comparing polyplexes of bPEI 25kDa and 
DOPE-PEI at the optimal N/P ratios (Fig. 2A and B) show that there is no beneficial effect of 
DOPE-conjugation in terms of a reduction of cytotoxicity. While DOPE-PEI based polyplexes are 
less cytotoxic than polyplexes based on bPEI 25kDa at corresponding vector concentrations, this 
benefit is eliminated by the larger amounts of DOPE-PEI necessary to achieve the same knockdown 
effect as with bPEI 25kDa. On the other hand, DOPE-PEI may have advantageous formulation 
properties; the hydrocarbon moiety of DOPE-PEI could enable formulation into liposomes or 
establish otherwise impossible lipid-lipid interactions as described by Sawant et al. with DNA cargo 
[26]. 
One aspect where DNA and siRNA polyplexes based on bPEI differ is the stability against 
polyanions such as heparin; siRNA polyplexes with bPEI 25kDa are much more sensitive to 
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heparin mediated decondensation than siRNA polyplexes with bPEI 1.8kDa and DOPE-PEI. This 
was surprising since we have observed the opposite for DNA, where a heparin:DNA ratio of 10 
results in 15% decondensation for bPEI 25kDa-polyplexes and 70% for bPEI 1.8kDa-polyplexes 
(unpublished results). This difference between DNA and siRNA is probably due to the smaller size 
of the siRNA compared to the DNA plasmids, which allow a more efficient packing of the siRNA, 
and the effect is probably assisted by the higher conformational rigidity of bPEI 25kDa compared to 
bPEI 1.8 kDa and DOPE-PEI [45]. Thus, for siRNA, bPEI 1.8 kDa and DOPE-PEI appear to form 
stronger interactions with the siRNA than bPEI 25kDa. 
The size measurements in HBG (Fig. 4A) demonstrate that all three polycations are able to 
condense siRNA and form particles that are smaller than 200 nm, which is believed to be the upper 
size limit of clathrin-mediated endocytosis [46]. Furthermore, the zeta potential measurements, 
PicoGreen exclusion and gel shift assays (Fig. 4B, Fig. 5 and Supplementary Fig. 2, respectively) 
confirm that at the N/P ratio that gives optimal transfection efficiency (N/P3 for bPEI 25kDa and 
N/P16 for DOPE-PEI), vector in excess of the requirements for maximum achievable siRNA 
condensation is present. In addition, the cytotoxicity results (Fig. 1 and 2) show that the free vector 
polymers are much more cytotoxic than polyplexes containing an equivalent amount of polymer, 
and that the toxicity increases markedly when going from N/P2 to N/P3 for bPEI 25kDa or from 
N/P5 to N/P16 for DOPE-PEI. Combined, these data support that at the optimal N/P ratios two 
vector fractions exist, one that is tightly bound in the core polyplex and one which is less tightly 
associated (a free fraction), each fraction with potentially different functions in the transfection 
process. 
The results demonstrate key differences between siRNA and DNA condensation as well as 
differences between the regular bPEIs and DOPE-PEI. Firstly, bPEI 25kDa condenses siRNA better 
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than DNA [30,32], probably due to the smaller size of the siRNA duplexes compared to the DNA 
plasmids. Secondly, much higher N/P ratios are required for full siRNA condensation by DOPE-
PEI than the conventional bPEIs. One possible explanation for this could be that DOPE-PEI is 
unable to pair as many of its charged nitrogens as regular bPEI due to steric hindrance.  
The observation that a free fraction of vector is necessary for efficient knockdown, prompted us to 
examine the role of the free vector in the form of experiments with simultaneous determination of 
knockdown and siRNA uptake and experiments with delayed addition of the free fraction. 
For bPEI 25kDa, the delay experiments show that the free fraction is not associated to the siRNA-
containing polyplexes, since separate addition of excess vector material to fully condensed siRNA-
containing polyplexes (N/P2) results in knockdown statistically identical to the knockdown 
achieved with optimally formulated polyplexes (Fig. 8A-C). DOPE-PEI does not fully share the 
behavior of bPEI 25kDa. Even though delayed addition of the free fraction does have a significant 
impact on the knockdown, it does not reach the level of knockdown of optimally formulated 
polyplexes (N/P16) (Fig. 8D-F). This probably reflects the altered cell-polymer interactions due to 
the ability to form lipid-lipid interactions. 
The siRNA uptake data (Fig. 9) demonstrate that the polyplexes based on bPEI 25kDa N/P3 and 
DOPE-PEI N/P16 are internalized to approximately the same extent, corresponding well to the 
induction of comparable knockdown in our HT1080 cell line. Conversely, polyplexes based on 
bPEI 1.8kDa are unable to induce knockdown and show only limited uptake, demonstrating that 
lipid conjugation of low Mw bPEI with the intent to increase membrane interaction is a constructive 
strategy [26,28]. Surprisingly, bPEI 25kDa consistently facilitates higher siRNA uptake at N/P2 
than N/P3 (P<0.001) although large knockdown requires the free fraction. This shows that the free 
fraction exerts its influence separately from the siRNA-containing core polyplexes, and the higher 
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uptake by N/P2 than N/P3 bPEI 25kDa polyplexes suggests that the free fraction plays a role 
unrelated to uptake. This could be by facilitating endosomal escape or by facilitating alternate 
routes of polyplex uptake such as the caveolar pathway as suggested by Pack et al. [19] or direct 
membrane fusion as proposed for lipoplex uptake [47]. 
It is widely reported that bPEI 1.8kDa is inefficient for DNA delivery while bPEI 25kDa is highly 
efficient [30], and we confirm this trend for siRNA. Many published reports on DNA transfection 
have compared polyplexes of these two polymers prepared at the same N/P ratio, which should 
provide the two polymers with equal proton-sponge capability. Our data shows that it is the 
internalization step that causes the efficiency gap between bPEI 1.8kDa and bPEI 25kDa, not 
necessarily the ability to induce endosomal escape. This hypothesis is in agreement with the work 
of Navarro and coworkers [48], who reported that the use of high N/P ratios and chloroquine did not 
enable bPEI 1.8kDa to induce knockdown. It is likely that it is the interaction with the plasma 
membrane that differs, although the specific mechanism for this membrane interaction remains to 
be elucidated. One structural advantage of bPEI 25kDa over bPEI 1.8kDa could be the ability to 
more efficiently cross-bind multiple anionic membrane proteins on the target cell plasma 
membrane, potentially influencing the uptake process through this interaction. Indeed, cross-
binding of cell surface receptors has been shown to be able to induce clathrin-mediated endocytosis 
through signaling [49,50] and it would be compatible with the uptake improvement observed for 
lipid conjugated bPEI 1.8kDa, since lipid conjugation may increase membrane interactions and 
therefore potentially improve bPEI 1.8kDa’s ability to induce endocytosis. Alternatively, it is 
possible that insertion of the lipid portion of DOPE-PEI into the plasma membrane induces 
membrane invaginations, which may facilitate endocytosis similar to observations by Cheng and 
coworkers [51]. 
23	
	
The proton sponge effect has been hypothesized to cause an increase in the pH and osmotic 
swelling of PEI-containing lysosomes resulting in loss of membrane integrity and leakage of the 
nucleic acid cargo into the cytosol [9,18]. We have previously shown that no change in lysosomal 
pH can be observed for bPEIs 25kDa [37]. However, DOPE-PEI show different properties and 
behavior, and as the free fraction appear to play a role after polyplex uptake, we investigated if the 
lipid conjugation would change the ability of DOPE-PEI to influence lysosomal pH. We measured 
the pH in the lysosomes of cells exposed to the three vectors, but were unable to measure any 
perturbation of the pH by any of the PEIs compared to the untreated control cells. The positive 
control cells treated with Bafilomycin A1 displayed the expected increase in pH [38,39]. However, 
even though we do not observe an increase in pH, the PEI polymer could still cause influx of first 
H+, then Cl- and water but with the V-ATPase being able to compensate and maintain the pH in the 
lysosomes. Osmotic swelling may then cause transient leakage events resulting in release of siRNA 
into the cytosol. The end result would be endosomal escape assisted by the proton sponge effect but 
without a concomitant drop in pH. 
Finally, the efficiency of induced knockdown versus siRNA uptake is much lower for all the tested 
PEI vectors compared to the commercial control, RNAimax. The latter is noticeably more efficient 
than both bPEI 25kDa and DOPE-PEI with an uptake percentage that never exceeds 2% (of the 
siRNA) while inducing a knockdown comparable to bPEI 25kDa and DOPE-PEI. This high 
efficiency is attractive, as less interaction with both siRNA and vector polymers potentially lower 
the cytotoxicity.  
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5. Conclusions 
Our experiments demonstrate the complexity of the cell-polyplex interactions. The importance of 
the free fraction for bPEI 25kDa and DOPE-PEI is evident - in its absence, the vectors are 
substantially less efficient. The considerable uptake of polyplexes of bPEI 25kDa at N/P2 and 
DOPE-PEI at N/P5 without concomitant knockdown indicates that the most important role of the 
free fraction is unrelated to polyplex uptake. Regardless of the specific role of the free fraction, 
future development of delivery systems for siRNA should consider the presence and potential role 
of a free vector fraction and how this can be controlled for in vivo delivery purposes. Lipid 
conjugation of bPEI 1.8kDa does not in itself provide the solution to the high cytotoxicity of bPEI 
25kDa or the low efficiency of bPEI 1.8kDa. However, DOPE-PEIs ability to form lipid-based 
interactions may enable it or a similar compound to be formulated into e.g. liposomes that can have 
in vivo transfection potential. 
 
6. Disclosure 
There are no conflicts of interest. 
  
 
Acknowledgments 
Financial support from the Danish Council for Strategic Research and the Technical University of 
Denmark is gratefully acknowledged for funding. 
25	
	
 
Appendix A. Supplementary data  
Supplementary data associated with this article can be found, in the online version, at http://….  
26	
	
References 
 
[1] R.C.C. Ryther, A.S. Flynt, J.A. Phillips, J.G. Patton, siRNA therapeutics: big potential from 
small RNAs, Gene Ther. 12 (2005) 5–11. 
 
[2] K.A. Whitehead, R. Langer, D.G. Anderson, Knocking down barriers: advances in siRNA 
delivery, Nat. Rev. Drug Discov. 8 (2009) 129–38. 
 
[3] P.D. Zamore, T. Tuschl, P.A. Sharp, D.P. Bartel, RNAi: double-stranded RNA directs the 
ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals, Cell. 101 (2000) 25–33. 
 
[4] S. Elbashir, W. Lendeckel, T. Tuschl, RNA interference is mediated by 21-and 22-nucleotide 
RNAs, Genes Dev. (2001) 188–200. 
 
[5] M.E. Davis, J.E. Zuckerman, C.H.J. Choi, D. Seligson, A. Tolcher, C.A. Alabi, Y. Yen, J.D. 
Heidel, A. Ribas, Evidence of RNAi in humans from systemically administered siRNA via 
targeted nanoparticles, Nature. 464 (2010) 1067–70. 
 
[6] C.E. Thomas, A. Ehrhardt, M.A. Kay, Progress and problems with the use of viral vectors for 
gene therapy, Nat. Rev. Genet. 4 (2003) 346–58. 
 
[7] D.W. Pack, A.S. Hoffman, S. Pun, P.S. Stayton, Design and development of polymers for 
gene delivery, Nat. Rev. Drug Discov. 4 (2005) 581–93. 
 
[8] M.A. Mintzer, E.E. Simanek, Nonviral vectors for gene delivery, Chem. Rev. 109 (2009) 
259–302. 
 
[9] O. Boussif, F. Lezoualc’h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, J.P. Behr, 
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: 
polyethylenimine, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7297–301. 
 
[10] U. Lungwitz, M. Breunig, T. Blunk, A. Göpferich, Polyethylenimine-based non-viral gene 
delivery systems, Eur. J. Pharm. Biopharm. 60 (2005) 247–66. 
 
[11] M. Neu, D. Fischer, T. Kissel, Recent advances in rational gene transfer vector design based 
on poly(ethylene imine) and its derivatives, J. Gene Med. 7 (2005) 992–1009. 
 
[12] L. Parhamifar, A.K. Larsen, A.C. Hunter, T.L. Andresen, S.M. Moghimi, Polycation 
27	
	
cytotoxicity: a delicate matter for nucleic acid therapy—focus on polyethylenimine, Soft 
Matter. 6 (2010) 4001. 
 
[13] W.T. Godbey, K.K. Wu, A.G. Mikos, Poly(ethylenimine) and its role in gene delivery, J. 
Control. Release. 60 (1999) 149–60. 
 
[14] B. Urban-Klein, S. Werth, S. Abuharbeid, F. Czubayko, A. Aigner, RNAi-mediated gene-
targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo, 
Gene Ther. 12 (2005) 461–6. 
 
[15] J.-C. Bologna, G. Dorn, F. Natt, J. Weiler, Linear polyethylenimine as a tool for comparative 
studies of antisense and short double-stranded RNA oligonucleotides, Nucleosides. 
Nucleotides Nucleic Acids. 22 (2003) 1729–31. 
 
[16] W.T. Godbey, K.K. Wu, A.G. Mikos, Tracking the intracellular path of 
poly(ethylenimine)/DNA complexes for gene delivery, Proc. Natl. Acad. Sci. U. S. A. 96 
(1999) 5177–81. 
 
[17] D. Hoekstra, J. Rejman, L. Wasungu, F. Shi, I. Zuhorn, Gene delivery by cationic lipids: in 
and out of an endosome, Biochem. Soc. Trans. 35 (2007) 68–71. 
 
[18] J.P. Behr, The proton sponge: a trick to enter cells the viruses did not exploit, Chim. Int. J. 
Chem. 2 (1997) 34–36. 
 
[19] N.P. Gabrielson, D.W. Pack, Efficient polyethylenimine-mediated gene delivery proceeds via 
a caveolar pathway in HeLa cells, J. Control. Release. 136 (2009) 54–61. 
 
[20] K. Sandvig, S. Pust, T. Skotland, B. van Deurs, Clathrin-independent endocytosis: 
mechanisms and function, Curr. Opin. Cell Biol. 23 (2011) 413–20. 
 
[21] K. Sandvig, M.L. Torgersen, H.A. Raa, B. van Deurs, Clathrin-independent endocytosis: 
from nonexisting to an extreme degree of complexity, Histochem. Cell Biol. 129 (2008) 267–
76. 
 
[22] P. Thomsen, K. Roepstorff, M. Stahlhut, B. van Deurs, Caveolae are highly immobile plasma 
membrane microdomains, which are not involved in constitutive endocytic trafficking, Mol. 
Biol. Cell. 13 (2002) 238–250. 
 
[23] R.L. Kanasty, K.A. Whitehead, A.J. Vegas, D.G. Anderson, Action and reaction: the 
biological response to siRNA and its delivery vehicles, Mol. Ther. 20 (2012) 513–24. 
28	
	
 
[24] H.M. Aliabadi, B. Landry, R.K. Bahadur, A. Neamnark, O. Suwantong, H. Uludağ, Impact 
of lipid substitution on assembly and delivery of siRNA by cationic polymers, Macromol. 
Biosci. 11 (2011) 662–72. 
 
[25] V. Incani, A. Lavasanifar, H. Uludağ, Lipid and hydrophobic modification of cationic 
carriers on route to superior gene vectors, Soft Matter. 6 (2010) 2124. 
 
[26] R.R. Sawant, S.K. Sriraman, G. Navarro, S. Biswas, R.A. Dalvi, V.P. Torchilin, 
Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery, 
Biomaterials. 33 (2012) 3942–51. 
 
[27] W.J. Kim, C.-W. Chang, M. Lee, S.W. Kim, Efficient siRNA delivery using water soluble 
lipopolymer for anti-angiogenic gene therapy, J. Control. Release. 118 (2007) 357–63. 
 
[28] G. Navarro, R.R. Sawant, S. Essex, C. Tros de Ilarduya, V.P. Torchilin, Phospholipid-
polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery, Drug 
Deliv. Transl. Res. 1 (2011) 25–33. 
 
[29] G. Navarro, R.R. Sawant, S. Biswas, S. Essex, C. Tros de Ilarduya, V.P. Torchilin, P-
glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin 
resistance in breast cancer cells, Nanomedicine. 7 (2012) 65–78. 
 
[30] Z. Dai, T. Gjetting, M.A. Mattebjerg, C. Wu, T.L. Andresen, Elucidating the interplay 
between DNA-condensing and free polycations in gene transfection through a mechanistic 
study of linear and branched PEI, Biomaterials. 32 (2011) 8626–34. 
 
[31] Y. Yue, F. Jin, R. Deng, J. Cai, Y. Chen, M.C.M. Lin, H.-F. Kung, C. Wu, Revisit 
complexation between DNA and polyethylenimine - Effect of uncomplexed chains free in the 
solution mixture on gene transfection, J. Control. Release. 155 (2011) 67–76. 
 
[32] Y. Yue, F. Jin, R. Deng, J. Cai, Z. Dai, M.C.M. Lin, H.-F. Kung, M.A. Mattebjerg, T.L. 
Andresen, C. Wu, Revisit complexation between DNA and polyethylenimine - Effect of 
length of free polycationic chains on gene transfection, J. Control. Release. 152 (2011) 143–
51. 
 
[33] J. Sambrook, D.W. Russel, Molecular Cloning: A Laboratory Manual vol. 1-3, 3rd ed., Cold 
Spring Harbour Laboratory Press, Cold Spring Harbour, New York, 2001. 
 
[34] R.V. Søndergaard, J.R. Henriksen, T.L. Andresen, Design, calibration and application of 
29	
	
broad-range optical nanosensors for determining intracellular pH, Nat. Protoc. 9 (2014) 
2841–2858. 
 
[35] R.V. Søndergaard, N.M. Christensen, J.R. Henriksen, E.K.P. Kumar, K. Almdal, T.L. 
Andresen, Facing the Design Challenges of Particle-Based Nanosensors for Metabolite 
Quantification in Living Cells, Chem. Rev. 115 (2015) 8344–8378. 
 
[36] R.V. Benjaminsen, H. Sun, J.R. Henriksen, N.M. Christensen, K. Almdal, T.L. Andresen, 
Evaluating nanoparticle sensor design for intracellular pH measurements, ACS Nano. 5 
(2011) 5864–73. 
 
[37] R.V. Benjaminsen, M.A. Mattebjerg, J.R. Henriksen, S.M. Moghimi, T.L. Andresen, The 
possible “proton sponge ” effect of polyethylenimine (PEI) does not include change in 
lysosomal pH, Mol. Ther. 21 (2013) 149–57. 
 
[38] B. van Deurs, P.K. Holm, K. Sandvig, Inhibition of the vacuolar H(+)-ATPase with 
bafilomycin reduces delivery of internalized molecules from mature multivesicular 
endosomes to lysosomes in HEp-2 cells, Eur. J. Cell Biol. 69 (1996) 343—350. 
 
[39] T. Yoshimori, A. Yamamoto, Y. Moriyama, M. Futai, Y. Tashiro, Bafilomycin A1, a specific 
inhibitor of vacuolar-type H+-ATPase, inhibits acidification and protein degradation in 
lysosomes of cultured cells, J. Biol. Chem. 266 (1991) 17707–17712. 
 
[40] S. Boeckle, K. von Gersdorff, S. van der Piepen, C. Culmsee, E. Wagner, M. Ogris, 
Purification of polyethylenimine polyplexes highlights the role of free polycations in gene 
transfer, J. Gene Med. 6 (2004) 1102–11. 
 
[41] P. Erbacher, T. Bettinger, P. Belguise-Valladier, S. Zou, J.L. Coll, J.P. Behr, J.-S. Remy, 
Transfection and physical properties of various saccharide, poly(ethylene glycol), and 
antibody-derivatized polyethylenimines (PEI), J. Gene Med. 1 (1999) 210–22. 
 
[42] S.Y. Tzeng, P.H. Yang, W.L. Grayson, J.J. Green, Synthetic poly(ester amine) and 
poly(amido amine) nanoparticles for efficient DNA and siRNA delivery to human 
endothelial cells, Int. J. Nanomedicine. 6 (2011) 3309–22. 
 
[43] I.S. Zuhorn, U. Bakowsky, E. Polushkin, W.H. Visser, M.C.A. Stuart, J.B.F.N. Engberts, D. 
Hoekstra, Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of 
genetic cargo and transfection efficiency, Mol. Ther. 11 (2005) 801–10. 
 
[44] M. Radwan Almofti, H. Harashima, Y. Shinohara, A. Almofti, Y. Baba, H. Kiwada, Cationic 
liposome-mediated gene delivery: Biophysical study and mechanism of internalization, Arch. 
30	
	
Biochem. Biophys. 410 (2003) 246–253. 
 
[45] Z. Dai, C. Wu, How Does DNA Complex with Polyethylenimine with Different Chain 
Lengths and Topologies in Their Aqueous Solution Mixtures?, Macromolecules. 45 (2012) 
4346–4353. 
 
[46] J. Rejman, V. Oberle, I.S. Zuhorn, D. Hoekstra, Size-dependent internalization of particles 
via the pathways of clathrin- and caveolae-mediated endocytosis, Biochem. J. 377 (2004) 
159–69. 
 
[47] J.J. Lu, R. Langer, J. Chen, A Novel Mechanism Is Involved in Cationic Lipid-Mediated 
Functional siRNA Delivery, Mol. Pharm. 6 (2009) 763–771. 
 
[48] G. Navarro, S. Essex, R.R. Sawant, S. Biswas, D. Nagesha, S. Sridhar, C.T. de ILarduya, 
V.P. Torchilin, Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-
mediated gene silencing: Implications for transfection and the role of lipid components, 
Nanomedicine Nanotechnology, Biol. Med. 10 (2014) 411–419. 
 
[49] A. Utskarpen, R. Massol, B. van Deurs, S.U. Lauvrak, T. Kirchhausen, K. Sandvig, Shiga 
toxin increases formation of clathrin-coated pits through Syk kinase, PLoS One. 5 (2010) 
e10944. 
 
[50] G. Scita, P.P. Di Fiore, The endocytic matrix, Nature. 463 (2010) 464–73. 
 
[51] Z. Cheng, R. Singh, D. Sharma, E. Holicky, K. Hanada, D. Marks, R. Pagano, Distinct 
mechanisms of clathrin-independent endocytosis have unique sphingolipid requirements, 
Mol. Biol. Cell. 17 (2006) 3197–3210. 
 
  
31	
	
Figures 
 
Figure 1. Cytotoxicity of vector polymers. The cells were treated with increasing concentrations of 
polymer for 24 h. DOPE-PEI denotes DOPE-conjugated bPEI 1.8kDa. Results are presented as 
mean of triplicates ± SD. Trend lines are 5 parameter fits. The figure is representative of three 
independent experiments. 
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Figure 2. Cytotoxicity of polyplexes. A. bPEI 25kDa, B. DOPE-PEI, C. bPEI 1.8kDa. The cells 
were treated with increasing concentrations of polymer for 24 h. For reference, the total vector 
concentration in our in vitro assays at N/P3 is 0.667 µg/mL (bPEI 25kDa, bPEI 1.8kDa) and 5.2 
µg/mL at N/P16 (DOPE-PEI). DOPE-PEI denotes DOPE-conjugated bPEI 1.8kDa. Results are 
presented as mean of triplicates ± SD. Trend lines are 4 parameter fits. Representative of three 
independent experiments each. 
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Figure 3. Lysosomal pH in response to bPEI 1.8kDa, bPEI 25kDa, DOPE-PEI or Bafilomycin A1.  
DOPE-PEI denotes DOPE-conjugated bPEI 1.8kDa. HT1080pLUC cells with internalized 
nanosensor for 16 h were treated with bPEI 1.8kDa, bPEI 25kDa or DOPE-PEI for 6 h and imaged 
at the indicated time points. A. Histograms showing pH distributions of nanosensor containing cells 
without further treatment (Control) or treated with bPEI 25kDa, bPEI 1.8kDa, DOPE-PEI or 
Bafilomycin A1 (Baf). Bafilomycin A1 was always added 40 min prior to measurement. Data 
points are mean values ± SEM. B. Representative images of cells obtained after 6 h of incubation. 
4.0 4.5 5.5 6.53.5 5.0 6.0 4.0 4.5 5.5 6.53.5 5.0 6.0
0
0.02
0.04
0.06
0.08
0.10
0.12
0
0.02
0.04
0.06
0.08
0.10
0.12
pH
Fr
eq
ue
nc
y
Control Baf bPEI 25kDa DOPE-PEI bPEI 1.8kDa
2 hours 6 hours
10 hours 24 hours
5 10 15 20
1
5
4
3
2
Time (hours)
pH
Control DOPE-PEI
4.0 4.5 5.5 6.53.5 5.0 6.0
pH
Control Baf DOPE-PEI
Br
ig
ht
 fi
el
d
pH
 im
ag
e
A
B C
0
pH
34	
	
Top row: bright field images. Bottom row: pH images. The ratio of the original pH-sensitive and 
reference signals was converted to pH via a calibration curve and images color coded according to 
the linear pH scale. No difference is observed between the control cells and the DOPE-PEI treated 
cells, whereas a clear change in color from yellow/green to cyan can be observed between the 
control cells and the Bafilomycin A1 treated cells. C. Measurements of lysosomal pH in response to 
DOPE-PEI over time compared to untreated control cells. Presented is mean ± SD of the pH 
frequency distributions obtained in A. Time-point zero was collected just before addition of vector. 
Representative of three independent experiments. 
 
Figure 4. Size and zeta potential as a function of N/P ratio. Scatter symbols represent polydispersity 
for the corresponding polyplex. A. Size. B. Zeta potential. DOPE-PEI denotes DOPE-conjugated 
bPEI 1.8kDa. Three separate preparations per N/P ratio, error bars represent SD.  
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Figure 5. Condensation of siRNA by bPEI 25kDa, DOPE-PEI and bPEI 1.8kDa. Condensation 
assessed by PicoGreen exclusion following addition of increasing amounts of vector to a constant 
amount of siRNA. The PicoGreen fluorescence intensity for siRNA in the absence of any vector 
was set to 100%. DOPE-PEI denotes DOPE-conjugated bPEI 1.8kDa. Results are presented as 
mean of triplicates ± SD. Trend lines are 5 parameter fits. Representative of four independent 
experiments. 
 
Figure 6. Heparin induced decondensation of polyplexes. Increasing amounts of sodium heparin 
was added to the polyplex dispersions and incubated for 30 min before PicoGreen assay. The 
PicoGreen fluorescence intensity for siRNA in the absence of any vector was set to 100%. DOPE-
PEI denotes DOPE-conjugated bPEI 1.8kDa. Results are presented as mean of triplicates ± SD. 
Trend lines are 5 parameter fits. Representative of three independent experiments. 
0 2 4 6 8 10 12
0
20
40
60
80
100
bPEI 25kDa
DOPE-PEI
bPEI 1.8kDa
N/P ratio
Fl
uo
re
sc
en
ce
 (%
 o
f f
re
e 
siR
N
A)
0 5 10 15 20
0
10
20
30
40
50
bPEI 1.8kDa, N/P2
bPEI 25kDa, N/P2
DOPE-PEI, N/P5
Heparin (µg/mL)
Fl
uo
re
sc
en
ce
 (%
 o
f f
re
e 
si
R
N
A)
36	
	
 
Figure 7. In vitro knockdown of luciferase expression. A: bPEI 25kDa, B: DOPE-PEI, C: bPEI 
1.8kDa. N = Negative control cells, P = Positive control cells (RNAimax), NS = Non-sense siRNA 
(anti-GFP siRNA). Cells were incubated with polyplexes prepared at varying N/P ratios. RLU = 
relative light units and DOPE-PEI = DOPE-conjugated bPEI 1.8kDa. Results are presented as mean 
of triplicates ± SD. Representative of three independent experiments. 
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Figure 8. In vitro knockdown of luciferase expression with delayed addition of the excess fraction 
of vector. A-C: bPEI 25kDa, D-F: DOPE-PEI. The cells were incubated with fully condensed 
polyplexes for 2 h, followed by addition of the free polymer and incubation for 1 h (A and D), 2 h 
(B and E), or 4 h (C and F) to a total incubation time with polyplexes and polymer of 3, 4 or 6 h. 
The cells were then washed and incubated to a total of 28 h. Neg = Negative control cells, Pos = 
Positive control cells (RNAimax). “3h N/P2” and “3h N/P5” = cells incubated for 3 h with fully 
condensed polyplexes – no free polymer added, “3h N/P3” and “3h N/P16” = cells incubated for 3 h 
with optimally formulated polyplexes – no free polymer added, “3h N/P2 (1h N1)” and “3h N/P5 
(1h N11)” = cell incubated for 2 h with fully condensed polyplexes, where after free polymer was 
added to a total polymer amount corresponding to optimally formulated polyplexes. RLU = relative 
light units and DOPE-PEI = DOPE-conjugated bPEI 1.8kDa. Results are presented as mean of 
triplicates ± SD. Representative of three independent experiments. (*) = significantly different by t-
test (p<0.005).  
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Figure 9. In vitro determination of siRNA internalization and knockdown of luciferase expression. 
The cells were incubated with polyplexes of the indicated N/P ratio and analyzed for both 
knockdown of luciferase expression and uptake of siRNA. Neg = Negative control cells, Pos = 
Positive control cells (RNAimax), siRNA = cells incubated with siRNA in the absence of vector, 
RLU = relative light units, and DOPE-PEI = DOPE-conjugated bPEI 1.8kDa. Results are presented 
as mean of triplicates ± SD. Representative of three independent experiments. (**) = significantly 
different by t-test (p<0.001). 
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Supplementary Figure 1. Phase contrast images of HT1080pLUC cells exposed to pH-nanosensor 
and/or different bPEIs. HT1080 cells were either treated with nanosensor for 16 h (+Nanosensor) or 
left without nanosensor (÷Nanosensor) for the same time. Cells with and without nanosensor were 
then treated with either of the following PEIs: bPEI 1.8kDa, bPEI 25kDa or DOPE-PEI for up to 6 
h or left untreated, followed by washing and incubation up to 24 h. Phase contrast images were 
captured of the cells after 2, 6, 10 and 24 h. Scale bars, 75 µm. 
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Supplementary Figure 2. Condensation of siRNA by bPEI 25kDa (A), DOPE-PEI (B), and PEI 
1.8kDa (C), visualized by gel electrophoresis. Identical amounts of siRNA in all lanes. The numbers 
below the lanes refer to N/P ratios, 0 = free siRNA, M = MW marker. 
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